Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study

PURPOSE: Clopidogrel is widely used in coronary artery, peripheral arterial, and cerebrovascular disease. We aimed to study the association of the CYP2C19 phenotype with cardiovascular outcomes and interventional procedures in a hospital-based population. PATIENTS AND METHODS: This cross-sectional,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yi-Ju, Hsiao, Tzu-Hung, Lin, Ching-Heng, Hsu, Chun-Sheng, Chang, Yen-Lin, Chen, Yu-Wei, Hsu, Chiann-Yi, Chen, Yi-Ming, Wu, Ming-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819696/
https://www.ncbi.nlm.nih.gov/pubmed/35140503
http://dx.doi.org/10.2147/PGPM.S335860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819696/
https://www.ncbi.nlm.nih.gov/pubmed/35140503
http://dx.doi.org/10.2147/PGPM.S335860

Ejemplares similares